CVS Health Corp [CVS] is 12.77% higher this YTD. Is it still time to buy?

CVS Health Corp [NYSE: CVS] slipped around -2.98 points on Wednesday, while shares priced at $66.6 at the close of the session, down -4.28%.

CVS Health Corp stock is now 12.77% up from its year-to-date (YTD) trading value. CVS Stock saw the intraday high of $69.11 and lowest of $66.54 per share. The company’s 52-week high price is 72.51, which means current price is +50.99% above from all time high which was touched on 05/01/25.

Compared to the average trading volume of 9.79M shares, CVS reached a trading volume of 10813430 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about CVS Health Corp [CVS]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $79.26 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Leerink Partners have made an estimate for CVS Health Corp shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 13, 2025. The new note on the price target was released on February 12, 2025, representing the official price target for CVS Health Corp stock.

The Price to Book ratio for the last quarter was 1.09, with the Price to Cash per share for the same quarter was set at 10.05. Price to Free Cash Flow for CVS in the course of the last twelve months was 14.18 with Quick ratio for the last quarter at 0.63.

How has CVS stock performed recently?

CVS Health Corp [CVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.35. With this latest performance, CVS shares gained by 4.72% in over the last four-week period, additionally plugging by 49.70% over the last 6 months – not to mention a rise of 48.36% in the past year of trading.

CVS Health Corp [CVS]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corp [CVS] shares currently have an operating margin of 3.05% and a Gross Margin at 14.02%. CVS Health Corp’s Net Margin is presently recorded at 1.39%.

Return on Equity for this stock inclined to 2.09%, with Return on Assets sitting at 2.09%.

Earnings analysis for CVS Health Corp [CVS]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corp go to 13.80%.

Insider trade positions for CVS Health Corp [CVS]

There are presently around $87.36%, or 88.31%% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 116.35 million shares, which is approximately 9.2635%. BLACKROCK INC., holding 100.15 million shares of the stock with an approximate value of $$5.91 billion in CVS stocks shares; and BLACKROCK INC., currently with $$3.64 billion in CVS stock with ownership which is approximately 4.9111%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.